LAS VEGAS — As drug costs and spending continue to rise, the demand for solutions opens the door to closer collaboration between payers and manufacturers. | LAS VEGAS — As drug costs and spending continue to rise, the demand for solutions opens the door to closer collaboration between payers and manufacturers.
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
Drug spending is rising sharply, with high-cost GLP-1 medications driving nearly half of the incr | How RxSense helped a health…
As medical costs continue to rise, employers are weighing a return to policies that shift additional expense to workers,…
Health insurance executives convene this week in Las Vegas at a time when the industry is facing significant pressure around…
Despite steady demand for obesity medications, 49% of payers who do not currently cover GLP-1s for obesity would not do so at any…
Nearly 80% of payers now prefer implementing vendor-built artificial intelligence tools rather than developing internal…
The payer that waits is the payer that loses. Cognizant's 2026 research reveals how AI-assistable tasks across health plan…
